Russell Investments Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $274M | Buy |
4,543,724
+53,923
| +1% | +$3.14M | 0.29% | 49 |
|
|
2025
Q4 | $242M | Buy |
4,489,801
+820,751
| +22% | +$39.5M | 0.26% | 61 |
|
|
2025
Q3 | $165M | Buy |
3,669,050
+728,381
| +25% | +$34M | 0.19% | 96 |
|
|
2025
Q2 | $136M | Sell |
2,940,669
-216,303
| -7% | -$10.6M | 0.17% | 116 |
|
|
2025
Q1 | $192M | Buy |
3,156,972
+296,321
| +10% | +$17.3M | 0.26% | 67 |
|
|
2024
Q4 | $162M | Buy |
2,860,651
+714,693
| +33% | +$39.9M | 0.22% | 72 |
|
|
2024
Q3 | $111M | Buy |
2,145,958
+406,019
| +23% | +$19M | 0.16% | 132 |
|
|
2024
Q2 | $72.3M | Sell |
1,739,939
-1,194,357
| -41% | -$53.4M | 0.12% | 183 |
|
|
2024
Q1 | $159M | Buy |
2,934,296
+702,122
| +31% | +$35.8M | 0.25% | 70 |
|
|
2023
Q4 | $115M | Buy |
2,232,174
+132,813
| +6% | +$6.97M | 0.2% | 98 |
|
|
2023
Q3 | $122M | Sell |
2,099,361
-288,926
| -12% | -$17.7M | 0.24% | 76 |
|
|
2023
Q2 | $153M | Buy |
2,388,287
+105,062
| +5% | +$7.05M | 0.29% | 57 |
|
|
2023
Q1 | $158M | Buy |
2,283,225
+285,099
| +14% | +$20.1M | 0.31% | 53 |
|
|
2022
Q4 | $144M | Buy |
1,998,126
+93,591
| +5% | +$7.06M | 0.3% | 60 |
|
|
2022
Q3 | $136M | Buy |
1,904,535
+104,976
| +6% | +$7.62M | 0.3% | 54 |
|
|
2022
Q2 | $139M | Buy |
1,799,559
+60,015
| +3% | +$4.57M | 0.28% | 61 |
|
|
2022
Q1 | $127M | Sell |
1,739,544
-321,942
| -16% | -$21.6M | 0.22% | 89 |
|
|
2021
Q4 | $129M | Buy |
2,061,486
+443,873
| +27% | +$26M | 0.21% | 95 |
|
|
2021
Q3 | $96.1M | Sell |
1,617,613
-162,019
| -9% | -$10.7M | 0.16% | 134 |
|
|
2021
Q2 | $119M | Buy |
1,779,632
+16,008
| +0.9% | +$1.04M | 0.2% | 100 |
|
|
2021
Q1 | $111M | Buy |
1,763,624
+375,065
| +27% | +$23.3M | 0.2% | 94 |
|
|
2020
Q4 | $86.1M | Buy |
1,388,559
+44,302
| +3% | +$2.72M | 0.17% | 123 |
|
|
2020
Q3 | $80.9M | Sell |
1,344,257
-290,046
| -18% | -$17.5M | 0.17% | 125 |
|
|
2020
Q2 | $95.6M | Sell |
1,634,303
-4,272
| -0.3% | -$256K | 0.21% | 94 |
|
|
2020
Q1 | $90.6M | Sell |
1,638,575
-574,759
| -26% | -$35.1M | 0.23% | 85 |
|
|
2019
Q4 | $142M | Sell |
2,213,334
-187,123
| -8% | -$10.7M | 0.26% | 63 |
|
|
2019
Q3 | $121M | Sell |
2,400,457
-121,481
| -5% | -$5.71M | 0.24% | 87 |
|
|
2019
Q2 | $114M | Sell |
2,521,938
-456,514
| -15% | -$21.3M | 0.21% | 95 |
|
|
2019
Q1 | $142M | Buy |
2,978,452
+330,317
| +12% | +$16.5M | 0.26% | 72 |
|
|
2018
Q4 | $137M | Buy |
2,648,135
+748,639
| +39% | +$40.2M | 0.31% | 54 |
|
|
2018
Q3 | $118M | Buy |
1,899,496
+347,207
| +22% | +$20.6M | 0.22% | 87 |
|
|
2018
Q2 | $85.9M | Sell |
1,552,289
-379,736
| -20% | -$20.5M | 0.18% | 112 |
|
|
2018
Q1 | $122M | Buy |
1,932,025
+239,319
| +14% | +$15.4M | 0.21% | 93 |
|
|
2017
Q4 | $105M | Buy |
1,692,706
+76,137
| +5% | +$4.76M | 0.18% | 116 |
|
|
2017
Q3 | $103M | Buy |
1,616,569
+331,642
| +26% | +$19.4M | 0.18% | 119 |
|
|
2017
Q2 | $71.6M | Sell |
1,284,927
-450,525
| -26% | -$24.5M | 0.13% | 183 |
|
|
2017
Q1 | $94.4M | Buy |
1,735,452
+41,170
| +2% | +$2.26M | 0.17% | 129 |
|
|
2016
Q4 | $99.8M | Buy |
+1,694,282
| New | +$92.6M | 0.19% | 116 |
|
Other funds holding BMY
VCM
VPM
Russell Investments Group's BMY Position: Q1 2026 in Review
Russell Investments Group increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, buying an estimated $3.14M and bringing the position to 4,543,724 shares worth $274M. The position accounts for 0.29% of the portfolio, ranked #49.
Russell Investments Group first reported a position in BMY in Q4 2016 and has held it in 38 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Russell Investments Group held 4,543,724 shares of Bristol-Myers Squibb worth $274M as of Q1 2026.
- Russell Investments Group bought 53,923 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.14M.
- Bristol-Myers Squibb made up 0.29% of Russell Investments Group's portfolio in Q1 2026, its #49 holding.
- Russell Investments Group first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 38 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.